Adriamycin and cis‐platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation

A. M. Langevin, A. Pierro, P. Liu, R. M. Filler, M. L. Greenberg

Producción científica: Articlerevisión exhaustiva

15 Citas (Scopus)

Resumen

Hepatoblastoma deemed surgically unresectable at presentation is fatal unless conversion to resectability is attained. We report a series of six consecutive patients, ranging in age from newborn to 5.75 years with hepatoblastoma unresectable at presentation, either because of size of tumor or its anatomical boundaries, or because of metastatic disease. All were treated with preoperative continuous infusions of cis‐platinum and Adriamycin. All achieved resect‐ability, and there was only one operative death. The five surviving patients are alive and free of disease off therapy. Potential benefit may accrue from preoperative chemotherapy in most cases of hepatoblastoma.

Idioma originalEnglish (US)
Páginas (desde-hasta)181-184
Número de páginas4
PublicaciónMedical and Pediatric Oncology
Volumen18
N.º3
DOI
EstadoPublished - 1990
Publicado de forma externa

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pediatrics, Perinatology, and Child Health

Huella

Profundice en los temas de investigación de 'Adriamycin and cis‐platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation'. En conjunto forman una huella única.

Citar esto